E-7386

N/A

Report date: 2025/01/11 20:00:12
NME

Base Information

Drug NameE-7386
Drug Alias NameE-7386
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActioncAMP-response element binding protein inhibitorsCatenin beta 1 inhibitorsWnt signalling pathway inhibitors
TargetscAMP-response element binding proteinCatenin beta 1
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsLiver Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEisai Co LtdPrism Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai LtdEisai IncEisai Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsLiver Neoplasms +[7] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A